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Abstract
Background: Prevention and antiretroviral therapy (ART) management for human immunodeficiency virus (HIV)
infected people need to have long-term health care. An empowerment focused intervention is a procedure by
which HIV infected people obtain combined possession of programs to attain mainly cost-effective HIV outcomes
and deal with social and structural difficulties related to their universal health access and human rights.
Empowerment is a key approach for addressing HIV related issues that focuses on addressing a broader context.
However, the practices of empowerment based approaches are sparse. We assessed the effect of an intervention to
empower HIV infected people receiving ART.
Methods: In this open-label randomized controlled trial, HIV infected people from Nepal who were using ART from
6 to 24 months and were aged 18 years and above were randomly assigned to receive either the intervention or
routine care. The intervention was led by two counselors for a period lasting six weeks. Participants were followed
up at three and six months after the baseline. The primary outcome was change in empowerment scores, analyzed
by using Difference-in-Difference (DiD).
Results: Between September and November 2014, 1447 HIV infected people were screened, of whom 132 were
randomly assigned to the intervention (n = 66) or control (n = 66) group. All the participants completed the 3- and
6- months follow up. A significant difference in mean empowerment score was found between the groups at 3-
(46.77, p-value <0.001) and 6- (49.71, p-value <0.001) months follow up. The average treatment effect (after
matching intervention and control individuals) showed that the participants who received the intervention
increased their mean empowerment scores from baseline by 47.05 (p-value <0.001, at three months) and 49.87
(p-value <0.001, at six months) than those who did not receive the intervention. No adverse events were reported.
Conclusion: Social self-value intervention provided to HIV infected people during ART increased their
empowerment. This intervention can be expanded to be utilized in routine services.
Trial registration: Thai Clinical Trials Registry, number TCTR20140814002.
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Background
Morbidity and mortality due to human immunodeficiency
virus (HIV) infections can be reduced by preventing new
HIV infections [1–3]. Globally, an estimated two million
people were newly HIV infected in 2014 [4]. Viral load
status of HIV in HIV positive people and risky sexual be-
havior with HIV uninfected people is the first and foremost
way of transmission of HIV [5]. HIV transmission could be
potentially reduced through interventions given at every
step of the HIV care continuum including an efficient diag-
nosis system, adherence to medical care, suppression of
viral load, and quality of antiretroviral treatment [6, 7].
Continuous intervention of medical care, treatment,
counseling and screening might help to reduce HIV
transmissions [8–10]. Persons who are HIV positive
but ignorant of their HIV status have more risk behav-
iors of HIV transmission than those who were con-
scious of their infection [11, 12]. Reduction of HIV
transmission is associated with antiretroviral treat-
ment (ART) and maintaining a high retention rate in
medical treatment is essential to gaining access to
ART and suppression of HIV viral load [8, 9, 13].
Universal access to treatment for those who need ART
is very low [4, 14]. In addition, antiretroviral drug toxicity,
resistance and non infectious developments are the major
challenges for maintaining a higher retention rate in regu-
lar medical care [15–17]. Furthermore, low negotiation
skills of risky sexual behavior with sexual partners, social
problems, co-infections and re-infections make HIV in-
fected people more vulnerable [18, 19]. Existing studies of
HIV interventions and non-interventions have focused on
primary and secondary prevention of subgroups and clin-
ical implications for mortality and morbidity rather than
the possible outcome for HIV prevention among all HIV
infected people [6, 7, 20–24]. Moreover, overambitious
targets related to HIV including zero new infections, dis-
crimination and stigma have been established by various
agencies [25–27]. However, gold standard interventions
have been unable to address those targets. An empower-
ment approach would be an asset to achieve above HIV
related inequalities and targets [28–31]. While health out-
comes and self care behaviors are linked to empowerment
methods with a supportive social environment, it must be
considered for implementation in programs and policies
to increase epidemiological profits on investment [32, 33].
An empowerment approach has not yet been developed
and tested for all HIV infected people. Empowerment is a
cost-effective approach to reduce HIV transmission, im-
prove treatment retention, and reduce social, physical and
psychological problems [34, 35]. This social self-value inter-
vention package was developed on the basis of the diffusion
model of innovations study [36]. The concept of social
action and empowerment theories were used to enhance
self-efficacy, self-care, family and social relationships, stigma
and discrimination issues [37–41] which are the major
obstacles among HIV populations. As a result, self-esteem,
autonomy, social adaptation or relationship and behavior
change for structural prevention as an empowerment
framework could be strengthened [20–24, 42, 43]. We
aimed to assess the effect of this intervention on empower-
ment of HIV infected people receiving ART.
Methods
Study design, settings and participants
This open label, parallel, randomized controlled trial was
conducted in Kathmandu, Nepal. HIV infected participants
receiving antiretroviral treatment (ART) from ART centers
of Kathmandu district of Nepal were recruited. The study
was conducted from September 2014 to June 2015. The
study site was Sukraraj Tropical and Infectious Disease
Hospital (STIDH), Teku, Kathmandu run by the govern-
ment of Nepal and was a part of the National Center for
AIDS and STD Control (NCASC) [44]. This site is the lar-
gest ART center catering to both rural and urban people
living in Nepal. It has provided multidisciplinary clinical
and laboratory services and treatment for HIV infected
people since 2004 [45]. Figure 1 shows details of the study
design and participant enrollment.
Eligible participants included HIV infected people aged
18 years or above, willing to participate in either interven-
tion or control arm, and had been receiving ART between
6 and 24 months prior to the study according to the ART
criteria as per the guidelines of NCASC [46]. We excluded
participants who were exposed to similar educational pro-
grams or any other intervention, expressed inability to
attend all the study follow up periods, suffering from health
problems (psychotic disorders, visual and hearing prob-
lems), and unwilling to disclose their HIV status among
other participants.
A total sample size of 132 participants (66 in the con-
trol arm and 66 in the intervention arm) would achieve
80 % power to detect a significant mean difference of
empowerment scores at a level of 0.05. Since, no previ-
ously published study was found for the mean change
of intervention (μ1 -μ2), a 20 % mean difference was ap-
plied which was equal to 0.52 standard deviation (σ).
The formula for testing the difference between two
means (two-sample t-test) was used to arrive at the
sample size.
Randomization and masking
Participants were randomly allocated to either the
intervention or control arm with a ratio of 1:1.
Randomization was performed by a random number
generator with permuted blocks of six. Allocation con-
cealment was done by using sequentially numbered
opaque sealed envelopes. The independent data man-
ager generated the randomly sequence numbers. The
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sequence numbers were masked from other research
staff and participants. None of the research team members
and participants was involved in the randomization process
and subsequent to randomization none of the participants
were able to modify their assignment. Enumerator and ana-
lysis assessor were masked from baseline to follow-up data
by using a unique code. The unique code was developed
for all the participants by the team leader to maintain the
anonymity of the participants.
Intervention procedures
Many theories were followed to develop the intervention
package. The intervention contents were developed based
on social learning, social action, and pedagogy theory and
empowerment principles for HIV prevention and treatment
[20–24, 37–43].
All the participants completed a baseline survey before
the intervention began. Once participants were recruited
and assigned their allocation baseline characteristics
were collected.
All participants who met the selection criteria were in-
formed about the study process, design and goals. All
subjects in the intervention group attended six interven-
tion sessions of one and half hours duration at the ART
center. Intervention sessions were conducted once per
week and per session eight to ten participants were in-
cluded. All the sessions were led by two national level
trainers with public health degrees. The intervention ses-
sions were as follows: first session covered rapport build-
ing, sharing uncomfortable situations and management
of negativity; second session started with barriers and
strategies of HIV disclosure and defeat with stigma and
self-esteem; third session covered healthy body and
healthy mind, healthy sexual relations, means to be HIV
infected or non-infected to be a man or woman, sexual-
ity, adherence of ART and other treatment and preven-
tion strategies after infection; fourth session started with
strategies to plan for healthy relations with family mem-
bers, the community and society, effective communica-
tion, and responsibilities in the society; fifth session
discussed negative effects of illicit drugs, alcohol, and
smoking, skills for co-infection, re-infection and part-
ner’s sexual behavior, diet and exercise; sixth session ed-
ucated about legal empowerment, human rights, legal
protection, discrimination, stress, rising voice together
against discrimination and rights and future goals.
Acceptability, applicability and relevancy of the inter-
vention contents were discussed with two experts, three
HIV infected people and two counselors. After necessary
amendment, the contents for all six sessions were pre-
Fig. 1 Study design and participant enrolment flow diagram. Legend: *Patients transferred out or did not come to the center during recruitment
period. #intention-to-treat design
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tested among ten HIV infected people. Participatory
learning activities, buzz sessions, brain storming, lec-
turers, and discussion techniques were used in the inter-
vention sessions. Participants were instructed to discuss
the issues within their group and other participants. Par-
ticipants were encouraged to communicate with their
family members, peer groups, friends related to HIV
control, prevention, treatment and disclosure. Partici-
pants were assigned home assignments at the end of
each session for presentation at the next session. All the
participants in the intervention group were compensated
for each of their six sessions with an amount equivalent
to US $ 20 in the local currency. The control group did
not receive any compensation.
Fidelity of the intervention was maintained with con-
tinuous monitoring of the allocated time for topics,
methods and contents of the sessions by health officers
and the research team leader. In addition, anonymity
was maintained with a code and participants were
assured quality during the discussion sessions. To main-
tain compliance, at the end of the each session the coun-
selors motivated participants to participate in the next
session, encouraged voluntary independent participation
and provided gift vouchers. The overall participant re-
tention rate was 96.6 % in the intervention session.
Standard care
All participants received routine standard care as per the
NCASC guidelines [46]. This included pre ART counsel-
ing, routine medical and laboratory tests and monthly
follow up for ART. Standard care in Nepal is provided
by government organizations and ART is dispensed free
of cost.
Study procedures
Participants were asked to provide information on
demographics, empowerment and behaviors at baseline
and follow up (first follow up: 3 months after the base-
line and second follow up: 3 months after the first follow
up). To minimize the errors and enhance quality control,
double data entry was employed and extensively super-
vised by the research team leader. Anonymity and confi-
dentiality were maintained with assigned unique codes.
Intervention contents and tools were pre-tested before
baseline and follow up data collection.
Measures
Demographic characteristics included age, sex, ethnicity,
religion, occupation, education, marital status, children
and per capita family income.
The primary outcome was measured by using an em-
powerment scale developed by Rogers et al. [47], containing
a total of 28 items each measured on a four-point agree-
ment scale ranging from strongly disagree to strongly agree.
Total empowerment scores ranged from 28 to 112 consist-
ing of five subscales, namely self-efficacy/self-esteem (9-36
score), power–powerlessness (7-28 score), community ac-
tivism and autonomy (5-20 score), optimism and control
over the future (4-16 score) and righteous anger (3-12
score). First, the contents of the questionnaire were dis-
cussed with two experts who amended the language for
suitability with HIV patients. Further contents were revised
to be applicable to the Nepalese culture and contexts. The
content was then discussed with three HIV infected people
for clarity and acceptance, and amended accordingly. After
development of the revised version with experts and HIV
infected people, the final version was pretested among HIV
infected people. During the pre-test, no negative comments
or difficulties were encountered by participants. Internal
consistency, as measured by Cronbach’s alpha was 0.97.
disclosure of HIV status (coded as yes or no, if response
was yes then the number of persons disclosed was re-
corded and dichotomized as ≤3 persons or >3 persons).
These secondary outcomes were measured to assess the
effect of empowerment to patient’s behaviors which were
important to their health outcomes.
Statistical analyses
Demographic characteristics were compared between
the intervention and control group at baseline. Baseline
differences between the two groups were tested using
Fisher’s exact or Chi-squared test for categorical vari-
ables and unpaired t-tests or Wilcoxon’s signed rank test
for continuous variables as appropriate.
Analysis of the primary outcome emphasized the dif-
ferences of empowerment scores among HIV infected
people comparing between the intervention and control
groups at baseline (baseline difference or pre-difference)
and at 3- (post-difference at 3 months) and 6- month
post-intervention (post-difference at 6 months). The im-
pact of the intervention on empowerment was analyzed
by comparing Difference-in-Differences (DiD) scores.
The impact of the intervention was measured between
baseline difference and post difference at 3 months
(DiD3mo) and between baseline difference and post dif-
ference at 6 months (DiD6mo). The secondary outcomes
were analyzed at baseline, 3- and 6- months follow up
using univariate analysis. Significant differences among
intervention and control were measure using Fisher’s
exact test.
Difference in Differences (DiD)
DiD methods can be used to estimate causal relationships
[48]. DiD compare the differences in outcomes among the
intervention group in pre- and post-intervention and in-
volves indentifying similar differences among the control
group. We used DiD to compare outcomes between con-
trol and intervention groups at baseline, 3- and 6- months
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follow up [49]. Ordinary Least Square (OLS) with repeated
data for control and intervention group for baseline, 3-
and 6- month follow up periods produced standard errors
and DiD estimates. The equation considered as follows:
Yist ¼ As þ Bt þ cXist þ βIst þ eist
where empowerment is the outcome of interest,
denoted asYist for the individual of HIV infected i in ran-
domized group s (control or intervention) by time t (the
baseline and 3- or 6- months follow up) and Ist is an
indicator variable representing whether the intervention
has affected the group s at time t. As and Bt are fixed ef-
fects for the randomized group and time (baseline and
follow up) respectively, Xist are applicable individual
controls and eist is the error term. The impact of the
intervention was estimated by OLS with β estimation.
Means and standard errors were estimated by linear re-
gression. Following linear regression for the individual i:
Outcomei ¼ βo þ β1  periodi þ β2  treatedi
þ β3  periodi  treatedi þ ei
where, ^β3: is the DiD or impact.
The analyses were done with R and Stata (diff com-
mand) was used for estimating the DiD [50]. All tests
were two sided and a p-value of <0.05 indicated statis-
tical significance.
Ethical considerations
Comprehensive privacy was maintained during the study
period. Strict anonymity and confidentiality was main-
tained throughout the recruitment, intervention and
data collection process by using unique codes. A stand-
ard protocol was followed to maintain data safety and
confidentiality of the study data [51]. In agreement with
national guidelines and the principles of the declarations
of Helsinki, written informed consent was obtained from
all participants prior to enrollment. The right to with-
draw at any time and skip any question was offered to
all participants. We provided travel costs and reimburse-
ment during the intervention and follow up periods. Re-
searchers had no direct or financial benefits and
declared no conflict of interest.
This project was approved by the Research Ethics
Committee, Faculty of Medicine, Prince of Songkla
University, Thailand (reference no. 57-0146-18-5) and
approved by Institutional Ethical Review Committee
of Sukraraj Tropical and Infectious Disease Hospital
(STIDH), Nepal (063/071/72) prior to study initiation.
The trial was registered through trial registration
number TCTR20140814002 (www.clinicaltrials.in.th).
All the contents were reported as per the CONSORT
guidelines.
Results
A detail of the trial profile is shown in Fig. 1. One hundred
thirty-two participants were randomly assigned to receive
the intervention (n = 66) or no intervention (n = 66) be-
tween September and November 2014. 1447 individuals
were screened and of these, 1125 were ineligible, 180 de-
clined to participate and 10 were excluded due to being
transferred out or because they did not come to the center
during the recruitment period. All participants in both
groups were retained in the study at three and six months
follow-up (100 % retention rate).
No significant differences at baseline were observed in
demographic characteristics of the participants between
the intervention and control groups. The mean ages of
participants in the intervention and control groups were
36.3 and 35.8 years, respectively. The majority had a low
family income, was married and had children (Table 1).
The correlations among empowerment domains and
total empowerment score are presented in Fig. 2. Total
scores of empowerment were positively correlated with
the other five domains at baseline, 3- and 6- months fol-
low up. In the intervention group at the 6 months follow
up, power-powerlessness, community activism and au-
tonomy, optimism and control over the future were
negatively correlated with righteous anger, and were
lowly correlated with self-efficacy/self-esteem and right-
eous anger.
The impact of the intervention on empowerment is
presented in Table 2. The baseline difference (pre-differ-
ence) of empowerment scores between the intervention
and control groups were not significantly different.
Difference-in-Difference at 3- (46.77, p <0.001) and 6-
months (49.71, p <0.001) were significantly higher for
the intervention group in all domains of empowerment.
After standardization of scores for each domain, the
impact of the intervention on each domain of empower-
ment remained equal. Participants who received the
intervention increased their empowerment scores by an
average of 47.05 points (p-value < 0.001, DiD at three
months and baseline) and 49.87 points (p-value < 0.001,
DiD at six months and baseline) more than those who
did not receive the intervention, after propensity score
matching of intervention and control individuals (data
not shown).
Figure 3 depicts the trend of average empowerment
scores among the two groups at baseline, 3- and 6-
months follow up. The mean post-intervention score of
empowerment markedly increased among the interven-
tion group at 3 months but only slightly increased at
6 months, while the mean score for the control group
remained constant.
Table 3 shows pre- and post-intervention differences
on behavioral and clinical characteristics. From baseline
to 6 months, unprotected sexual intercourse with any
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partner decreased in the intervention group and in-
creased in the control group. The proportion of those
who ever forgot to take ART did not change in the inter-
vention group but the proportion rose from baseline to
6 months among the control group. No participant for-
got to take ART in the past week in the intervention
group. The proportion of participants who disclosed
their HIV status rose from baseline to 6 months in the
intervention group. Focusing on change from baseline to
6 months, statistically significant differences between the
control and intervention groups were found for unpro-
tected sexual intercourse (p-value <0.001), forgetting to
ever take ART (p-value 0.007), forgetting to take ART in
the past week (p-value <0.001), and disclosure of HIV
status (p-value <0.001).
Discussion
A social self-value intervention package was shown to em-
power HIV infected people receiving ART and improved
their behaviors. Our study highlighted a significantly greater
increase in empowerment for HIV infected people at 3-
and 6- months from the baseline. Similar findings were
highlighted by a quasi-experimental study from Canada
that anticipated empowering HIV infected people [52].
However, there are sparse existing studies available related
to empowerment of all HIV infected people [52, 53].
Baseline characteristics of the participants were not
statistically significant different among the intervention
and control groups. Further we collected background
characteristics (age, sex, ethnicity, marital status, date
ART started) for all the screened participants. There was
no difference in these background characteristics be-
tween those who agreed to participate in the study and
those who refused thus minimizing biological, environ-
mental and socioeconomic bias. The given reasons for
refusal to participate were lack of interest, time and per-
ceived need for the intervention. The strong recruitment
process enhanced a higher retention rate in the interven-
tion group and lower loss to follow up at 3- and 6-
months. The intervention sessions took place in the
same center where the controls received ART. This
could have increased the chance of contamination
among the control group. To reduce this risk, we con-
ducted the intervention after services had finished for
the day in each center and participants were counseled
not to disclose any activities during the study period.
The fact that the findings did not show any changes
among the control group after the intervention provides
evidence of no or minimal contamination. On the other
hand, provided incentives to the intervention group
could lead to confirmation bias. Incentivized group
might be more biased in their information than who did
not get incentives.
The total empowerment score was highly correlated
with its different domains but different domains were
loaded with various correlations from high (self-efficacy)
to low (righteous anger). Self-efficacy/self-esteem domain
revealed a significant enhancement at six months which
was similar to findings from previous studies using different
interventions for HIV infected populations [52, 54, 55]. It
was confirmed in a systematic review on community-based
interventions that empowerment intervention had positive
effects on self-esteem [56]. Self-esteem is necessary to







(n = 66) (n = 66)
Age (years)
Mean(SD) 35.8 (8.8) 36.3 (6.8) 0.71
≤36 36 (54.5) 41 (62.1) 0.48
>36 30 (45.5) 25 (37.9)
Gender 0.22
Female 39 (59.1) 31 (47)
Male 27 (40.9) 35 (53)
Ethnicity 0.60
Indigenous 31 (47.0) 27 (40.9)
Non-indigenous 35 (53.0) 39 (59.1)
Religion 0.44
Hindu 49 (74.2) 44 (66.7)
Others 17 (25.8) 22 (33.3)
Occupation 0.85
Unemployed 22 (33.3) 21 (31.8)
Informal employee 25 (37.9) 23 (34.8)
Formal employee 19 (28.8) 22 (33.3)
Education level 0.10
Illiterate informal 29 (43.9) 19 (28.8)
Primary and above 37 (56.1) 47 (71.2)
Marital status 0.10
Single 17 (25.8) 17 (25.8)
Married 49 (74.2) 49 (74.2)
Children 0.09
No 14 (21.2) 6 (9.1)
Yes 52 (78.8) 60 (90.9)
Number of children 0.08
≤2 39 (59.1) 50 (75.8)
>2 13 (19.7) 10 (15.2)
Family per-capita income
(USDa)
Median(IQR) 50 (30.67) 50 (30.67) 0.81
≤50 41 (62.1) 44 (66.7) 0.72
>50 25 (37.9) 22 (33.3)
a1USD 100NPR, IQR inter quartile range, SD standard deviation
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enhance the management of the negative social, physical
and emotional impacts of HIV infection, thus our interven-
tion was useful to support these issues.
Righteous anger domain was negatively correlated with
the other domains. This might be the effect of the interven-
tion that operates to reduce feelings of revenge over
perceived mistreatment among HIV infected people. In
addition, greatly increased righteous anger (reactive feeling
of fury over abuse) scores had a positive influence on social
and community adaption and adjustment of HIV infected
people. Our trial showed a significantly greater increase in
community activism and autonomy, power-powerlessness
Fig. 2 Correlation among domains and total empowerment score. Legend: empower: empowerment total score; selfesteem: self-esteem/self-efficacy;
power: power-powerlessness; autonomy: community activism and autonomy; optimism: optimism and control over the future; righteous:
righteous anger
Table 2 Impact of intervention on empowerment










Control Intervention Control Intervention Control Intervention
Empowerment (total score) 46.70 46.38 48.23 94.68 −0.32 46.45 46.77 46.53 95.92 49.39 49.71
Self-efficacy/self-esteem 15.27 15.03 15.39 30.33 −0.24 14.94 15.18 15.12 30.91 14.79 16.03
Power-powerlessness 12.00 12.03 12.26 23.92 0.03 11.67 11.64 11.67 24.18 12.51 12.48
Community activism and
autonomy
8.01 8.04 8.65 16.83 0.03 8.18 8.15 8.26 16.92 8.67 8.64
Optimism and control over
the future
6.59 6.50 6.61 13.54 −0.09 6.94 7.03 6.36 13.41 7.04 7.14
Righteous anger 4.82 4.77 5.32 10.04 −0.04 4.73 4.77 5.12 10.50 5.38 5.42
* = p <0.001; Pre-diff difference at baseline, Post-diff3mo difference at 3 month follow up, Post-diff6mo difference at 6 month follow up, DiD3mo difference at baseline
and 3 month follow up, DiD6mo difference at baseline and 6 month follow up
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(helpless and totally incompetent) and optimism and con-
trol over the future (hope and assurance about the future
or successful result of something). This may have affected
the capacity to rebalance and reincorporate their lives [57].
HIV infection might guide the person to the destruction of
their life goals, as well as absence of autonomy and self-
control. Powerlessness and lack of control over the future
appears as a diverse risk factor of disease. The impact of
the intervention was further validated by using an average
treatment effect model with propensity score matching.
This was done to reduce the bias, although the participants
were randomly assigned and no significant changes were
reported after the modeling. Findings revealed significant
improvements in empowerment score from baseline to
3 months follow up, but only minimal improvements at six
months. The improvements at three months might be due
to the immediate effect of the intervention while lack of
further improvements at 6 months is probably due to a ceil-
ing effect – the optimum empowerment score may have
already been achieved. However, this needs long-term
follow up to illicit the possible effects and reasons.
Our intervention improved not only empowerment
but also the behavior of HIV infected people most likely
because behavior related contents were included in the
intervention package. A systematic review of interven-
tions showed both significant and non-significant posi-
tive effects of interventions to reduce risk behaviors [58].
Our study found that the practice of unprotected sexual
Fig. 3 Trend of average empowerment score with 95 % confidence interval for intervention and control groups
Table 3 Pre- and post-intervention differences on behavioral and clinical characteristics
Baseline Three month follow up Six month follow up
Control Intervention P-value Control Intervention P-value Control Intervention P-value
(n = 66) (n = 66) (n = 66) (n = 66) (n = 66) (n = 66)
Unprotected sexual intercourse with
any partner in last 3 monthsa
0.82 0.001 0.001
No 38 (76.0) 36 (72.0) 19 (35.8) 47 (100.0) 19 (36.5) 45 (95.7)
Yes 12 (24.0) 14 (28.0) 34 (64.2) 0 (0) 33 (63.5) 2 (4.3)
Ever forgot to take ART 0.16 0.38 0.007
Yes 23 (34.8) 32 (48.5) 26 (39.4) 32 (48.5) 48 (72.7) 32 (48.5)
No 43 (65.2) 34 (51.5) 40 (60.6) 34 (51.5) 18 (27.3) 34 (51.5)
Forgot to take ART in past week 0.78 0.001 0.001
Yes 6 (9.1) 8 (12.1) 56 (84.8) 0 (0) 20 (30.3) 0 (0)
No 60 (90.9) 58 (87.9) 10 (15.2) 66 (100.0) 46 (69.7) 66 (100.0)
Disclosure of HIV status withb 0.93 0.001 0.001
≤ 3 persons 46 (80.7) 45 (77.6) 46 (76.7) 18 (27.3) 44 (73.3) 2 (3.0)
> 3 persons 11 (19.3) 13 (22.4) 14 (23.3) 48 (72.7) 16 (26.7) 64 (97.0)
aMissing data bamong disclosed, p-value = Fisher’s exact test
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intercourse among HIV infected people with any partner
was significantly reduced after the intervention. A sys-
tematic review on community empowerment interven-
tions for HIV prevention showed a reduction in risky
sexual behaviors and increase in condom use among sex
workers [59]. Another study related to empowerment of
young HIV infected people showed a significant im-
provement in protected sexual intercourse [55]. This
trial revealed a significant improvement in adherence to
ART among the intervention group and a decrease
among the control group. Previous interventions
highlighted that the empowerment of HIV infected
people showed an improvement in adherence to ART
[52, 60]. Our study highlighted a significant increase in
HIV status disclosure rate. Disclosure is important to
prevent the spread of HIV, increase the wisdom of self-
esteem, emotional and practical support from social
networks [61]. An empowerment intervention was envi-
sioned with a multi-level construct that entails an under-
standing of social adaptation or relationship, self-esteem,
autonomy, and behavior change for structural preven-
tion throughout the contribution of developed skills,
strengths and advocacy to behavioral, social inter-
dependence and cognitive changes. This outcome might
be the path of effect that is associated with empower-
ment theory.
Studies related to empowerment to all the HIV infected
people were not available in this region. Although applic-
able to local culture and context intervention package, a
highly experienced interventionist and extensive quality
control measure might be the reason for improvement of
empowerment scores and behavioral outcomes among the
intervention group. Although subgroup analysis was
found significant in small sample size and we suggested
evaluating in future multicenter and large sample size
based intervention and long term effects. An empower-
ment measurement tool would yield two dimensions of
self and community directions to empowerment. Commu-
nity orientation to empowerment believed that HIV in-
fected people have power inside the society and desire to
encourage community action in an unfriendly world. Self
orientations to empowerment believe themselves to be
self-esteem, self-efficacious, and optimistic to the future.
Strengths and limitations
This trial was based on randomly assigned participants,
a blinded analysis process and use of rigorous outcome
analysis guaranteeing high internal validity. The inter-
vention package and measurement tools were pre-tested
in different stages which increased its reliability. The
intervention package was found acceptable and feasible
after measurement by both qualitative and quantitative
approaches [62]. A high retention rate in the interven-
tion group as well as during follow up was maintained.
The intervention was conducted in the regular health
care service setting provided by the Nepalese govern-
ment which pretend the real world setting and added to
the external validity. Our study population characteris-
tics including socio-demographic and clinical features
were consistent with other HIV infected populations in
Nepal. Therefore, the results can be generalizable to
other HIV infected people. We verified participants ART
adherence with their records in the ART center to re-
duce the potential desirability of reporting and recall
biases. However, we did not execute the pill count
measure.
There were some limitations in this study. First, par-
ticipants were not blinded to the intervention. How-
ever, a rigorous coding system ensuring the anonymity
was used with enumerator for data collection, entry
and analysis. Second, reduced risky sexual behavior,
high adherence and disclosure rate found in this study
could be due to the Hawthorne effect (benefit of trial
participation in the intervention group), which can
eliminate the power to detect a factual difference from
a trial [63]. Drug toxicity, accessibility and attitude
might be potential confounders for adherence to ART.
Further, these changes might have happened due to so-
cial desirability bias. However, a good rapport building
during the intervention and data collection, familiar
enumerator and study settings to participants all helped
to reduce this bias. Third, a randomized controlled trial
is a dynamic design that can reduce bias due to con-
founding. However, there are inbuilt biases that might
be mostly pertinent in behavioral intervention trials.
Factors such as process of informed consent, study
measurement tools that are used many times and reim-
bursement for participation in the trial could add to
changes in behaviors among both control and interven-
tion groups. Fourth, this empowerment intervention
did not cover economic aspects. Finally, factor analysis
was not used due to sampling inadequacy. However,
after face validity and few modifications to language,
the reliability was tested and showed good internal
consistency. In other settings when empowerment
measurement tool will be applied, the validity and reli-
ability should be evaluated before use in different local
cultures and contexts.
Conclusion
The efficacy on empowerment of HIV infected people
using ART was shown after receiving the intervention.
Their risky sexual behaviors were reduced and their
adherence to ART and disclosure of HIV were increased.
The intervention contents can be utilized in regular ser-
vices and its effectiveness needs to be evaluated after
routine implementation. Further, the empowerment
intervention framework and method of measurement
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can be used in different settings after validating its cul-
tural and contextual acceptability and applicability.
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